ArticleAnnals of medicine and surgery (2012)2026
Augmented reality tumor mapping: eliminating positive margins in oncosurgery.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intraoperative measurement of breast-conserving surgery margins: surgical application.Breast cancer research : BCR · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Augmented reality (AR) is transforming cancer surgery by combining medical imaging with real-time visualization during operations. Using 3D digital models of tumors, AR allows surgeons to see the precise location and borders of cancers directly on the patient. Early studies in breast, brain, urologic, and skin cancers show that AR improves accuracy and helps surgeons remove tumors more completely and safely. Research from China and South Korea has demonstrated accurate margin identification in skin and breast tumor surgeries, while teams in Italy and Belgium have reported better surgical planning and shorter operation times in prostate and brain tumor procedures. AR is also being used to train surgeons in low-resource settings, improving access to advanced surgical methods worldwide. Positive surgical margins, which are associated with increased local recurrence rates and reduced survival, highlight the critical need for accurate intraoperative tumor visualization across tumor types. Although more clinical trials are needed to confirm its ability to reduce positive margins, AR-guided tumor mapping shows great promise as a standard tool to support safer, more precise oncologic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.